22 November 2019 Research Preferred product characteristics for therapeutive vaccines

22 Nov 2019 - 13:45

Professor Mark Hatherill has co-authored a journal article titled: "Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organisation consultations" appearing in the Vaccine journal.

To view journal article click here.